RDVT Red Violet, Inc. Insider Trading

CIO Jeffrey Alan Dell sells 10,000 RDVT shares for $574,350 at $57.44 avg; prior 5 sales at this ticker all well-timed (90-day negatives)

Jeffrey Alan Dell, Chief Information Officer of Red Violet, Inc., executed 2 separate sales totaling 10,000 shares for $574,350.00 on 2026-06-01, reducing his holdings by 6.0% to 155,889 shares. His prior trading history at RDVT shows a striking pattern: all 5 of his previous sales at this ticker were well-timed at the 90-day mark, with negative average returns (-6.4% to -7.3% at 30 days, -27.2% to -28.6% at 90 days), suggesting the insider has consistently sold ahead of subsequent declines. The current stock price of $59.30 remains -7.6% below the 52-week high of $64.14, and while the stock has appreciated +49.6% in the past 30 days and +34.0% over 90 days, the CIO's disciplined selling pattern warrants investor scrutiny. This transaction should be monitored against whether the pattern of well-timed exits continues to hold.

Red Violet CEO Derek Dubner sells 12,000 shares for $689,160.00; execution pattern consistent with prior sales

Derek Dubner, CEO of Red Violet (RDVT), executed 2 separate sales totaling 12,000 shares for $689,160.00 on June 1, 2026, at an average price of $57.43, reducing his holdings from 569,273 shares to 557,273 shares (-2.1%). The current stock price stands at $59.30, above the transaction prices but -7.6% from the 52-week high of $64.14. Notably, Dubner's prior 5 sales at RDVT over the preceding months all showed negative 90-day returns, with his entire trading history demonstrating a 100% well-timed sell rate at the 90-day mark across all tickers tracked. The stock has appreciated 49.6% over 30 days and 34.0% over 90 days from the transaction date, indicating the sale occurred before material upside. The company reports quarterly revenue of $25,830,000.00, net income of $4,388,000.00, 20.0% annual revenue growth, and a P/E of 59.30, reflecting a high valuation profile at a market cap of $836,659,015.30. The repetition of sequential sales with a consistent pattern of subsequent stock appreciation, combined with the elevated valuation metrics, warrants attention to whether the insider's decision-making framework may diverge from short-term performance trends.

CFO Daniel Maclachlan sold 12,000 shares at $57.43 avg; stock up 49.6% in 30d, near 52-week high ($64.14). All 5 prior RDVT sales were well-timed (90d negative returns).

Daniel Maclachlan, CFO of Red Violet, executed 2 separate sales totaling 12,000 shares for $689,160.00 on 2026-06-01 at a blended average price of $57.43, reducing his holdings by 3.2% to 358,902 shares. The current price of $59.30 is -7.6% from the 52-week high of $64.14, though the stock has rallied +49.6% over the prior 30 days. Notably, Maclachlan's prior 5 trades at RDVT were all well-timed at the 90-day mark, each showing negative 90-day returns ranging from -27.2% to -28.6%, suggesting a consistent pattern of selling before declines. His cross-ticker track record shows 7 prior sells with an average 90-day return of -28.5% and a 100.00% well-timed rate, further underscoring a demonstrated ability to exit before downturns. Investors should monitor whether this sale—coming after a +49.6% rally and near the 52-week high—represents another correctly-timed exit or a departure from his historical pattern.

Red Violet President James Patrick Reilly sold 12,000 shares ($689,160.00) on 2026-06-01 as stock rallies 49.6% in 30 days

James Patrick Reilly executed 2 separate sales totaling 12,000 shares for $689,160.00 at an average blended price of $57.43, reducing his holdings by 4.9% from 244,351 to 232,351 shares. The sale occurred as the stock trades at $59.30, up 49.6% over 30 days and 34.0% over 90 days from prior levels, within 7.6% of its 52-week high of $64.14. His prior 5 sales at RDVT all posted negative 90-day returns, with a 100.00% well-timed rate at this ticker, establishing a consistent pattern of selling before subsequent declines. The company reports strong fundamentals with revenue growth of 20.0% annually and a P/E of 59.30, but the insider's historical timing pattern at this specific ticker warrants attention to whether current valuations present execution opportunities or risk exposure.

CFO MacLachlan Daniel sold 15,000 shares (15.0K) at $57.86 avg on Nov 10–13, raising $867.9K; retains 358.2K shares.

MacLachlan Daniel, Chief Financial Officer of Red Violet, executed 7 separate sales totaling 15,000 shares for $867,942.57 over four trading days (Nov 10–13, 2025), at a blended average price of $57.86. This represents a 4.0% reduction of his pre-transaction holdings, leaving him with 358,163 shares. The stock has risen 8.9% over the prior 30 days and 31.9% over 90 days, trading at $57.51 currently and within 3.2% of its 52-week high of $59.42. The company's fundamentals show strong revenue growth (+24.9% year-over-year) and profitability ($4.2M net income on $23.1M quarterly revenue), though the P/E of 71.89 reflects a elevated valuation multiple. The CFO's partial reduction in share count during a strong price run and amid rich valuation metrics merits monitoring, particularly given the absence of disclosed trading plan information in this filing.

CEO Derek Dubner sells 15,000 shares at $57.86 avg; maintains 556.0K shares post-sale

Dubner Derek, CEO of Red Violet, Inc., executed 7 separate sales totaling 15,000 shares for $867,941.79 across a four-day window (2025-11-10 to 2025-11-13), with a blended average transaction price of $57.86. The sale represents a 2.6% reduction of his pre-transaction holdings of 571,000 shares, leaving him with 556,000 shares post-sale. The stock currently trades at $57.51, modestly below the blended sale price, and is within 3.2% of its 52-week high of $59.42. Red Violet has posted strong recent performance (90-day change +31.9%, 30-day change +8.9%) alongside solid fundamentals: FY revenue growth of +24.9%, most recent quarterly revenue of $23.1M, net income of $4.2M, and a market cap of $803.5M. The relatively modest share reduction, maintained substantial executive stake, and execution near the stock's 52-week highs warrant tracking but do not constitute a material directional signal without additional context on trading plan structure or other executive activity.

Red Violet CIO Jeffrey Alan Dell sold 10,000 shares ($578.6K) over Nov 10-13 at blended avg $57.86

Jeffrey Alan Dell, Chief Information Officer at Red Violet, executed 7 separate sales totaling 10,000 shares for $578,629.93 between November 10–13, 2025, at an average price of $57.86. His post-transaction holdings stand at 155,934 shares, representing a -6.0% reduction from prior holdings. The stock is currently trading at $57.51, near the blended sale price, and stands at -3.2% from its 52-week high of $59.42. The company shows strong recent momentum (30-day +8.9%, 90-day +31.9%) and healthy fundamentals (annual revenue growth +24.9%, net income $4,213,000 on $23.1M quarterly revenue, P/E 71.89). The sale's timing relative to the stock's broader trajectory and the insider's continued significant ownership (155.9K shares post-transaction) should be evaluated in context of the company's current valuation metrics and recent stock performance.

RDVT President Reilly James Patrick sold 15,000 shares across 7 transactions (Nov 10–13) for $867,943.29; retained 231,078 shares.

President Reilly James Patrick executed 7 separate sales totaling 15,000 shares for $867,943.29 over a four-day window (November 10–13, 2025) at a blended average price of $57.86. The stock is currently trading at $57.51, -3.2% from its 52-week high of $59.42, and has posted strong momentum (30-day: +8.9%, 90-day: +31.9%). With 231,078 shares retained post-transaction, the president's position represents meaningful ongoing exposure to the company. The sale reduces his holdings by 6.1%, a moderate reduction that occurred during a period of elevated valuation (P/E 71.89) and near the 52-week high range, though no scheduled trading plan or other context explaining the timing is indicated in this filing.

Director Stanton Lisa M. bought 1,000 shares of RDVT at $36.12; stock down 20.2% from 52-week high at $43.16.

Director Lisa M. Stanton purchased 1,000 shares at $36.12 on 2025-03-07, increasing her holdings from 25,815 shares to 26,815 shares. The purchase occurred near the lower end of the 52-week trading range ($16.78–$43.16), with the stock currently trading at $34.46, representing a -20.2% decline from its 52-week high and -12.6% decline over the prior 30 days. Red Violet generates $19.1M quarterly revenue with +24.9% annual revenue growth, though the P/E of 67.57 reflects elevated valuation relative to the $1.7M net income. The transaction size (1,000 shares) represents a modest 3.9% addition to Stanton's existing position, which warrants context regarding the filing's governance and intent.